CBNA

CBNA identifies coding and non-coding cancer drivers, including miRNA drivers, by analyzing condition-specific biological networks.

Key Features:

• Integration of Genomic Data Types: Integrates gene expression profiles, gene networks, and mutation data for combined analysis.
• Two-stage process: Constructs condition-specific networks and then identifies potential coding and miRNA cancer drivers.
• BRCA benchmarking: Demonstrated superior effectiveness in detecting coding cancer drivers on BRCA datasets compared to existing methods.
• Prediction of miRNA drivers: Predicts non-coding miRNA drivers and identified 17 miRNA drivers in breast cancer, with several supported by literature.
• Subtype-specific driver detection: Detects subtype-specific cancer drivers in breast cancer cohorts.
• EMT drivers discovery: Identifies epithelial–mesenchymal transition (EMT) coding and miRNA drivers relevant to metastasis and progression.

Scientific Applications:

• Coding and non-coding driver discovery: Identification of coding genes and miRNA drivers from integrated genomic datasets.
• Breast cancer research: Discovery and prioritization of breast cancer drivers, including application to BRCA datasets and miRNA driver prediction.
• Subtype-specific analysis: Characterization of genetic drivers specific to breast cancer subtypes for stratified studies.
• EMT and metastasis studies: Identification of EMT-associated drivers to investigate mechanisms of metastasis and progression.

Methodology:

Integrates gene expression profiles, gene networks, and mutation data; constructs condition-specific biological networks; and performs driver identification to detect coding genes and miRNAs.